CSIMarket


Aytu Biopharma Inc  (NASDAQ: AYTU)
Other Ticker:  
 

Aytu Biopharma Inc

AYTU's Fundamental analysis








Aytu Biopharma Inc's sales fell by -26.62 % in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 2077

Major Pharmaceutical Preparations industry recorded growth of revenues by 9.75 %

Aytu Biopharma Inc realized net income compared to net loss a year ago in I. Quarter 2024

More on AYTU's Growth


Aytu Biopharma Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 97.95 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.19.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.17.


More on AYTU's Valuation
 
 Total Debt (Millions $) 17
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 4,985,800
 Net Income/Employee (TTM) $ -416,667
 Receivable Turnover (TTM) 2.82
 Tangible Book Value (Per Share $) -2.35

Aytu Biopharma Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 97.95 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.19.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.17.

Aytu Biopharma Inc Price to Book Ratio is at 0.47 lower than Industry Avg. of 89.05. and higher than S&P 500 Avg. of 0.01

More on AYTU's Valuation

  Market Capitalization (Millions $) 14
  Shares Outstanding (Millions) 9
  Employees 15
  Revenues (TTM) (Millions $) 75
  Net Income (TTM) (Millions $) -6
  Cash Flow (TTM) (Millions $) 0
  Capital Exp. (TTM) (Millions $) 0
  Total Debt (Millions $) 17
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 4,985,800
  Net Income/Employee(TTM) $ -416,667
  Receivable Turnover Ratio (TTM) 2.82
  Tangible Book Value (Per Share $) -2.35

  Market Capitalization (Millions $) 14
  Shares Outstanding (Millions) 9
  Employees 15
  Revenues (TTM) (Millions $) 75
  Net Income (TTM) (Millions $) -6
  Cash Flow (TTM) (Millions $) 0
  Capital Exp. (TTM) (Millions $) 0





  Ratio
   Capital Ratio (MRQ) 0.99
  Total Debt to Equity (MRQ) 0.56
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.61
  Inventory Turnover Ratio (TTM) 1.82





Aytu Biopharma Inc net profit margin of 9.22 % is currently ranking no. 47 in Major Pharmaceutical Preparations industry, ranking no. 123 in Healthcare sector and number 1391 in S&P 500.

More on AYTU's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com